ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,778Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 324

$839K Total Retail Price of All Prescriptions

Rank: 29 out of 324

771 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 771 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 771 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 14,995 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 869 772 1 2
SIMVASTATIN 754 697 2 1
LISINOPRIL 576 513 3 3
FUROSEMIDE 564 541 4 7
WARFARIN SODIUM 481 444 5 10
LOSARTAN POTASSIUM 437 422 6 15
HYDROCODONE-ACETAMINOPHEN 424 390 S3 7 5
TRIAMTERENE-HCTZ 390 342 8 46
AMLODIPINE BESYLATE 370 365 9 4
ATORVASTATIN CALCIUM 355 304 10 12
ATENOLOL 326 304 11 18
POTASSIUM CHLORIDE 319 293 12 8
OMEPRAZOLE 316 311 13 6
SERTRALINE HCL 290 272 14 23
PANTOPRAZOLE SODIUM 228 173 15 34
METOPROLOL TARTRATE 228 216 15 14
GABAPENTIN 225 215 17 13
SPIRONOLACTONE 215 209 18 47
CRESTOR 202 170 19 28
ALLOPURINOL 200 186 20 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 198 183 21 35
ZOLPIDEM TARTRATE 193 154 22 20
ALENDRONATE SODIUM 184 179 23 24
METFORMIN HCL 179 153 24 9
AZITHROMYCIN 172 147 25 48
METOPROLOL SUCCINATE 169 168 26 17
KLOR-CON M20 139 138 27 52
ZETIA 134 115 28 68
GLIMEPIRIDE 129 116 29 37
NEXIUM 128 97 30 33
PREDNISONE 116 106 31 36
CIPROFLOXACIN HCL 108 97 32 55
DONEPEZIL HCL 106 106 33 25
NOVOLOG 104 100 34 60
IPRATROPIUM-ALBUTEROL 104 104 34 118
TAMSULOSIN HCL 103 95 36 26
TRAMADOL HCL 103 96 36 19
LANTUS 103 100 36 39
LOSARTAN-HYDROCHLOROTHIAZIDE 100 95 39 44
CLOPIDOGREL 98 85 40 38
LANTUS SOLOSTAR 98 80 40 85
HYDROCHLOROTHIAZIDE 92 85 42 11
TRAZODONE HCL 92 74 42 42
FLUTICASONE PROPIONATE 90 79 44 32
TRANDOLAPRIL 90 82 44 295
RANITIDINE HCL 86 51 46 58
FAMOTIDINE 83 67 47 62
FENOFIBRATE 82 81 48 79
MIRTAZAPINE 79 75 49 41
BISOPROLOL-HYDROCHLOROTHIAZIDE 77 76 50 145
CITALOPRAM HBR 77 72 50 16
POLYETHYLENE GLYCOL 3350 75 74 52 49
VENLAFAXINE HCL ER 72 67 53 86
LIPITOR 71 65 54 109
FINASTERIDE 71 69 54 101
CYCLOBENZAPRINE HCL 70 41 R 56 51
VYTORIN 70 67 56 140
MELOXICAM 69 61 58 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 56 59 91
PAROXETINE HCL 66 52 60 72
GEMFIBROZIL 65 61 61 93
CARBIDOPA-LEVODOPA 64 64 62 80
LEVETIRACETAM 63 54 63 120
PROPRANOLOL HCL 60 43 64 95
ZOSTAVAX 60 56 64 138
FELODIPINE ER 58 46 66 158
NAMENDA 58 58 66 31
LOVASTATIN 58 58 66 43
TERAZOSIN HCL 54 42 69 133
CYMBALTA 54 37 69 45
JANUVIA 53 53 71 83
DIGOXIN 52 48 72 40
PLAVIX 52 51 72 63
LEVOFLOXACIN 52 46 72 84
OXYBUTYNIN CHLORIDE 52 42 72 88
PROAIR HFA 50 36 76 50
GUANFACINE HCL 50 38 R 76 372
FROVA 50 0 10 76 372
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.